Nicole Green
Family · Destrehan, LANPI 1104105352
Payments from drug & device makers
Across 193 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$483
- AstraZeneca$206
- Teva Pharmaceuticals USA, Inc.$185
- Boehringer Ingelheim$172
- Novo Nordisk$154
- plus $887 from 16 others
What the payments were for
- Food & beverage$3,400100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 82 | $1,314 |
| Lilly USA, LLC | 29 | $483 |
| AstraZeneca | 8 | $206 |
| Teva Pharmaceuticals USA, Inc. | 7 | $185 |
| Boehringer Ingelheim | 10 | $172 |
| Novo Nordisk | 9 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $152 |
| Bayer | 8 | $152 |
| Pfizer | 7 | $136 |
| Exact Sciences | 4 | $74 |
| Johnson & Johnson | 5 | $72 |
| Paratek Pharmaceuticals, Inc. | 3 | $46 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Sanofi | 1 | $37 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $32 |
| Vanda Pharmaceuticals Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $27 |
| Abbott | 1 | $18 |
| Boston Scientific | 1 | $16 |
| Merck | 1 | $14 |
| Novartis | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$117
How this compares
$3,400 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 128 | $177,871 |
| MounjaroTirzepatide | 119 | $153,087 |
| LinzessLinaclotide | 49 | $67,456 |
| JardianceEmpagliflozin | 35 | $48,858 |
| TrulicityDulaglutide | 34 | $39,192 |
| JanuviaSitagliptin Phosphate | 26 | $33,231 |
| XareltoRivaroxaban | 16 | $24,627 |
| RybelsusSemaglutide | 13 | $23,923 |
| EliquisApixaban | 17 | $21,388 |
| VraylarCariprazine Hcl | 15 | $20,611 |
| FarxigaDapagliflozin Propanediol | 13 | $16,266 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $8,362 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 163 | $5,397 |
| Lidocaine | 37 | $5,045 |
| Humulin 70/30 KwikpenInsulin Nph Hum/Reg Insulin Hm | 14 | $4,299 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $154 | $201,794141 claims |
| Lilly USA, LLCMounjaro, Trulicity | $483 | $192,279153 claims |
| AbbVieLinzess, Vraylar | $1,314 | $88,06664 claims |
| Boehringer IngelheimJardiance | $172 | $48,85835 claims |
| MerckJanuvia | $14 | $33,23126 claims |
| Johnson & JohnsonXarelto | $72 | $24,62716 claims |
| PfizerEliquis | $136 | $21,38817 claims |
| AstraZenecaFarxiga, Symbicort | $206 | $19,40825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.
Other family in Destrehan
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.